UniChem/Gehe Battle Suspended

31 March 1996

- The battle between the UK's UniChem and Germany's Gehe for Lloyds Chemists of the UK has been suspended. The European Commission has decided to refer the L645 million ($982.7 million) bid by Gehe to the UK authorities, following the request of the UK government (Marketletters passim). The bid is expected to be referred to the UK Monopolies and Mergers Commission, which is also looking at the UniChem bid of L623 million for the chemist chain. The MMC will have four months to make a decision on the matter.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight